These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 16958942)
1. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study. Sato S; Yamakawa Y; Terashima Y; Ohta H; Asada T Psychiatry Clin Neurosci; 2006 Oct; 60(5):584-9. PubMed ID: 16958942 [TBL] [Abstract][Full Text] [Related]
2. Mood disorders after stroke: diagnostic validation of the poststroke depression rating scale. Quaranta D; Marra C; Gainotti G Cerebrovasc Dis; 2008; 26(3):237-43. PubMed ID: 18648195 [TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression. Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655 [TBL] [Abstract][Full Text] [Related]
4. Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness. Spalletta G; Guida G; De Angelis D; Caltagirone C J Neurol; 2002 Nov; 249(11):1541-51. PubMed ID: 12420095 [TBL] [Abstract][Full Text] [Related]
5. Emotional withdrawal, CT abnormalities and drug response in late life depression. Altamura AC; Bassetti R; Santini A; Frisoni GB; Mundo E Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):349-54. PubMed ID: 14751432 [TBL] [Abstract][Full Text] [Related]
7. Resolution of sexual dysfunction during acute treatment of major depression with milnacipran. Baldwin D; Moreno RA; Briley M Hum Psychopharmacol; 2008 Aug; 23(6):527-32. PubMed ID: 18536065 [TBL] [Abstract][Full Text] [Related]
8. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach. de Coster L; Leentjens AF; Lodder J; Verhey FR Int J Geriatr Psychiatry; 2005 Apr; 20(4):358-62. PubMed ID: 15799083 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of milnacipran on poststroke depression on inpatient rehabilitation. Yamakawa Y; Satoh S; Sawa S; Ohta H; Asada T Psychiatry Clin Neurosci; 2005 Dec; 59(6):705-10. PubMed ID: 16401247 [TBL] [Abstract][Full Text] [Related]
10. Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture. Lenze EJ; Munin MC; Dew MA; Rogers JC; Seligman K; Mulsant BH; Reynolds CF Int J Geriatr Psychiatry; 2004 May; 19(5):472-8. PubMed ID: 15156549 [TBL] [Abstract][Full Text] [Related]
11. Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis. Mandelli L; Serretti A; Colombo C; Florita M; Santoro A; Rossini D; Zanardi R; Smeraldi E Psychiatry Clin Neurosci; 2006 Oct; 60(5):598-604. PubMed ID: 16958944 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder. Lopez-Ibor JJ; Conesa A; Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743 [TBL] [Abstract][Full Text] [Related]
13. No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disorders. Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N Psychiatry Clin Neurosci; 2008 Apr; 62(2):197-202. PubMed ID: 18412843 [TBL] [Abstract][Full Text] [Related]
14. Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. Nys GM; van Zandvoort MJ; van der Worp HB; de Haan EH; de Kort PL; Kappelle LJ J Neurol Sci; 2005 Jan; 228(1):27-33. PubMed ID: 15607207 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease. Mizukami K; Hatanaka K; Tanaka Y; Sato S; Asada T Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):349-52. PubMed ID: 19166899 [TBL] [Abstract][Full Text] [Related]
16. Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients. Naito S; Sato K; Yoshida K; Higuchi H; Takahashi H; Kamata M; Ito K; Ohkubo T; Shimizu T Psychiatry Clin Neurosci; 2007 Aug; 61(4):421-7. PubMed ID: 17610668 [TBL] [Abstract][Full Text] [Related]
17. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Chen Y; Guo JJ; Zhan S; Patel NC Ann Pharmacother; 2006 Dec; 40(12):2115-22. PubMed ID: 17119102 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study on depressive state following stroke]. Kikumoto O Seishin Shinkeigaku Zasshi; 1990; 92(7):411-34. PubMed ID: 2236345 [TBL] [Abstract][Full Text] [Related]
19. The Post-Stroke Depression Rating Scale: a test specifically devised to investigate affective disorders of stroke patients. Gainotti G; Azzoni A; Razzano C; Lanzillotta M; Marra C; Gasparini F J Clin Exp Neuropsychol; 1997 Jun; 19(3):340-56. PubMed ID: 9268809 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study. Rampello L; Alvano A; Chiechio S; Raffaele R; Vecchio I; Malaguarnera M Arch Gerontol Geriatr; 2005; 40(3):275-85. PubMed ID: 15814161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]